What is XOMAP's current stock price?

XOMAP (XOMA Corporation) is currently trading at $25.36 with a market cap of $305.9M.

What sector is XOMA Corporation in?

XOMA Corporation (XOMAP) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

XOMAP XOMA Corporation

Healthcare

$25.36+0.08%ClosedMarket Cap: $305.9M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

21.09

PEG

0.03

P/B

4.40

P/S

14.44

EV/EBITDA

13.22

DCF Value

$-59.65

FCF Yield

1.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

93.3%

Operating Margin

13.7%

Net Margin

87.0%

ROE

30.2%

ROA

11.6%

ROIC

1.9%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$12.3M	$4.5M	$—
Q4 null	$1.4M	$6.1M	$—
FY null	$52.1M	$31.7M	$—
Q3 null	$532.0K	$14.1M	$—

Trading Activity

Insider Trades

View All

Hughes Owendirector, officer: Chief Executive Officer

SellWed Jan 10

Sitko Bradleyofficer: Chief Investment Officer

BuyWed Oct 04

Sitko Bradleyofficer: Chief Investment Officer

BuyWed Oct 04

Hughes Owendirector, officer: Exec Chairman and Interim CEO

BuyWed Oct 04

Hughes Owendirector, officer: Exec Chairman and Interim CEO

BuyWed Sep 27

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

0.90

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Peers

SLN